Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Synvitro Hyadase

K-Number: K200680 · 2020-07-17

Decision Date2020-07-17
Product CodeMQL
Advisory CommitteeOB
DecisionSubstantially Equivalent

Device Summary

Synvitro Hyadase is a medical device manufactured by Origio A/S, A Coopersurgical Company. It received FDA 510(k) clearance on 2020-07-17 under approval number K200680. The device is classified under product code MQL. It was reviewed by the OB advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Synvitro Hyadase?

Synvitro Hyadase is a medical device that received FDA 510(k) clearance on 2020-07-17. It is manufactured by Origio A/S, A Coopersurgical Company. The 510(k) number is K200680.

When was Synvitro Hyadase approved by the FDA?

Synvitro Hyadase received FDA 510(k) clearance on 2020-07-17, under approval number K200680.

What company makes Synvitro Hyadase?

Synvitro Hyadase is manufactured by Origio A/S, A Coopersurgical Company.

What is the FDA product code for Synvitro Hyadase?

The FDA product code for Synvitro Hyadase is MQL.

Related Devices (Code: MQL)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.